Biomedica Poland Sp. z o.o. secures contract for Laboratory reagents - 181/PN/2026 - Delivery of tests for molecular diagnostics of selected point mutations and molecular diagnostics of post-transplant infections and congenital infections in newborns using MGB probes along with the lease of analyzers for UCK

Poland, July 27 -- Poland based Biomedica Poland Sp. z o.o. has secured contract from Uniwersyteckie Centrum Kliniczne for Laboratory reagents - 181/PN/2026 - Delivery of tests for molecular diagnostics of selected point mutations and molecular diagnostics of post-transplant infections and congenital infections in newborns using MGB probes along with the lease of analyzers for UCK . The value of the contract is worth 2048934.99 PLN .

Published by HT Digital Content Services with permission from Pivotal Sources....